Oxoid Limited
Country not established
Part of Oxoid Ltd
Oxoid Limited is a medical device manufacturer, with 92 devices listed in FDA GUDID and EUDAMED (FDA Class I and II) and 1 FDA recall as of 14 Nov 2026.
- Devices
- 92
- FDA recalls
- 11 ongoing
Registry facts
- Registries
- FDA GUDID 92
- EUDAMED 46
- Device classes
- FDA Class I 48
- FDA Class II 44
- FDA recalls
- Sites and related companies
- Identifiers
- DUNS 365355452
At a glance
Market reach
- United States
- FDA recalls
What Oxoid Limited makes
Oxoid Limited manufactures in vitro diagnostic (IVD) products for microbiological testing, including culture media supplements, antimicrobial susceptibility testing discs, and serological reagents for identifying bacterial species and toxins. Their portfolio also includes fluorescent immunoassay kits for detecting respiratory viruses, such as parainfluenza and influenza, as well as atmospheric generation kits and software tools for automated identification of bacterial isolates.
The company’s devices are classified under FDA’s Class I and Class II regulatory categories and are listed in the FDA’s Unique Device Identifier (UDI) database. Oxoid Limited operates from the United States, adhering to applicable IVD regulations for diagnostic testing products.
Catalogue
Search and filter all 92 devicesShowing 1-50 of 92
Company details
- DUNS number
- 365355452
- Phone
- +441256694238
FDA recalls
FDA recall records list 1 recall initiated by OXOID LIMITED, initiated on 2024-12-23. By recorded status: 1 ongoing. The reasons filed fall into these groups: labeling or instructions for use, sterility or contamination and packaging. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
Recalls initiated per year
- 2017 0
- 2018 0
- 2019 0
- 2020 0
- 2021 0
- 2022 0
- 2023 0
- 2024 1
- 2025 0
- 2026 0
2024
- 23 Dec 2024 Z-1075-2025 Class II Ongoing Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.
Full distribution text
- 23 Dec 2024 Z-1075-2025 Class II Ongoing Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.
Frequently asked questions
How many devices does OXOID LIMITED have in the registry?
The registry currently lists 92 devices for OXOID LIMITED. Devices recorded under merged duplicate company entries are counted once.
Which registries list OXOID LIMITED's devices?
Among its 50 most recently registered devices, OXOID LIMITED has devices listed in EUDAMED (29 devices) and FDA GUDID (50 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do OXOID LIMITED's devices fall under?
Among its 50 most recently registered devices, the classes recorded for OXOID LIMITED's devices are Class I and Class II. Each device page shows its own class and authorisation.
Are there FDA recall records for OXOID LIMITED?
FDA recall records list 1 recall initiated by OXOID LIMITED, the most recent initiated on 23 Dec 2024. 1 of them is recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from OXOID LIMITED in the registry?
The most recently registered devices listed for OXOID LIMITED include Thermo Scientific Oxoid Gepotidacin Disc (10 ug) GEP10 CT1975B, MICROBACT GNB 24E TRAY (40 ID'S) MB1131A, CT0794B and MICROBACT PROGRAM FOR WINDOWS MB1244A.